First of its kind trial design expedites drug testing and expands patient access to new investigational products — ScienceDaily
A new paper in Annals of Neurology describes the approach, structure, and launch of the HEALEY ALS Platform Trial- the first platform trial for amyotrophic lateral sclerosis (ALS) designed to…
